Atlas Trials

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD

Clinical trial NCT02347761 · COMPLETED

Trial details

NCT number
NCT02347761
Sponsor
Sunovion Respiratory Development Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COPD
Start date
2015-02-01
Primary completion
2015-11-01
Enrollment
653

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.